Medications for Sickle Cell Anemia

6 results

  • Albumin (human) (albumin human)

    (Albumin Human)
    Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.
    Usage: ALBUMIN (HUMAN) 25% is indicated for treating hypovolemia, hypoalbuminemia in critically ill or active bleeding patients, maintaining cardiovascular function post-paracentesis for cirrhotic ascites, managing severe ovarian hyperstimulation syndrome, adjunct treatment for ARDS and acute nephrosis, and treating hyperbilirubinemia in hemolytic disease of the newborn.

  • Desmopressin acetate (desmopressin acetate)

    (Desmopressin acetate)
    Meitheal Pharmaceuticals Inc.
    Usage: Desmopressin Acetate Injection is indicated for managing central diabetes insipidus, temporary polyuria and polydipsia post-head trauma or surgery, hemophilia A, and mild to moderate von Willebrand's disease (Type I). It helps maintain hemostasis and reduce bleeding during surgeries and after injuries. Not effective for nephrogenic diabetes insipidus.

  • Droxia (hydroxyurea)

    (HYDROXYUREA)
    E.R. Squibb & Sons, L.L.C.
    Usage: DROXIA is indicated for reducing the frequency of painful crises and the need for blood transfusions in patients with sickle cell anemia who experience recurrent moderate to severe painful crises.

  • Ferriprox (deferiprone)

    (deferiprone)
    Chiesi USA, Inc.
    Usage: FERRIPROX Tablets are indicated for treating transfusional iron overload in adults and pediatric patients (8 years and older) with thalassemia syndromes, sickle cell disease, or other anemias. Safety and effectiveness are not established for use in myelodysplastic syndrome or Diamond Blackfan anemia.

  • Flexbumin (albumin human)

    (Albumin human)
    Takeda Pharmaceuticals America, Inc.
    Usage: FLEXBUMIN® 20% (Albumin [Human]) is indicated for hypovolemia, hypoalbuminemia, cardiopulmonary bypass surgery, and hemolytic disease of the newborn (HDN). It treats inadequate albumin levels due to various conditions including burns, infections, and severe injuries, and is used in specific surgical settings for blood dilution.

  • Xromi (hydroxyurea)

    (Hydroxyurea)
    Nova Laboratories, Ltd.
    Usage: XROMI is indicated for pediatric patients aged 6 months and older with sickle cell anemia to reduce the frequency of painful crises and the need for blood transfusions.